Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Registry Study for Real-World Outcome Analysis to Estimate the Incidence of FN Among Subjects Who Are at High Risk for FN, Have Non-myeloid Malignancies, and Are Receiving Udenyca for Prophylaxis of FN

NCT04662892 is registered in ClinicalTrials.gov with Coherus Oncology, Inc. as lead sponsor.

NCT NCT04662892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04662892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Registry Study for Real-World Outcome Analysis to Estimate the Incidence of FN Among Subjects Who Are at High Risk for FN, Have Non-myeloid Malignancies, and Are Receiving Udenyca for Prophylaxis of FN
Lead sponsor
Coherus Oncology, Inc.
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2020
Completion date
December 15, 2022
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

febrile neutropenia, non-myeloid malignancy